期刊文献+

铝螯合剂对染铝大鼠肾功能及必需元素的影响 被引量:4

Effect of aluminum chelating agent on renal function and essential elements of aluminum-induced rats
下载PDF
导出
摘要 目的:探讨铝螯合剂1,2-二甲基-3-羟基-4-吡啶酮(1,2-dimethyl-3-hydroxy-4-pyridone,DHPO)对铝染毒大鼠血清肌酐、尿素氮、尿酸及肾脏中铝、锌、铜、铁、钙、镁等元素的影响。方法:30只雄性Wistar大鼠随机分为6组,阴性对照组、铝染毒组、预防组及低、中、高剂量组,AlCl3染毒3周后分别给予不同剂量的DHPO 1周,测定血清肌酐、尿素氮、尿酸含量及肾脏中铝、锌、铜、铁、钙、镁等元素的含量。结果:铝染毒组尿素氮含量显著高于阴性对照组(P<0.05),其余各组与阴性对照组相比差异均无统计学意义;各组大鼠血清中肌酐、尿酸含量比较差异均无统计学意义。铝染毒组肾脏中Al含量显著高于阴性对照组(P<0.01),低、中、高剂量组均显著低于铝染毒组(P<0.01),且中、高剂量组与阴性对照组相比差异均无统计学意义;铝染毒组、低剂量组大鼠肾脏中铜含量均显著低于阴性对照组(P<0.01,P<0.05),而中、高剂量组与阴性对照组相比差异无统计学意义;低、中、高剂量组的大鼠肾脏中锌、铁、钙、镁的含量与阴性对照组相比差异均无统计学意义。结论:DHPO在促排铝的同时,对肾脏中锌、铜、铁、钙、镁含量无影响,且能使受损的肾功能得到恢复。 Objective: To investigate the effects of 1,2-dimethyl-3-hydroxy--4-pyridone (DHPO) on creatinine(Car), urea nitrogen(BUN) and uric acid(UA) in serum and on aluminum(M), zinc(Zn), copper(Cu), iron(Fe), calnum. Methods: Wistar ratscium(Ca) and magnesium(Mg) in the kidneys of rats induced by alumi were subjected to aluminum chloride for 3 weeks. Then they were treated with different doses of DHPO. The content of Cr, BUN and UA in the serum was determined, and the concentrations of Al, Zn, Cu, Fe, Ca and Mg in kidney tissues were determined. Results: The BUN content of the AI group was significantly lower than that of the negative control group. The result of UA and Cr contents demonstrated that there was no statistical significance among the groups. The Al level in the kidneys was significantly increased with an intake increase. The aluminum concentration of the three DHPO groups was significantly lower than that of the Al group( P 〈 0.01 ). The aluminum concentration of the moderate and high DHPO groups was not significantly different from that of the negative control group. The Cu concentration of the Al group and the low DHPO group was significantly lower than that of the negative control group, whereas there was no statistical significance between the moderate and high DHPO groups and the negative control group. Compared with the negative control group, the Zn, Fe, Ca, Mg concentrations of the low, moderate and high DHPO groups were not significantly different. Conclusion: DHPO could effectively promote the elimination of Al in kidneys, protect the kidney from Al-induced damage, and has no effect on the excretion of Zn, Cu, Fe, Ca and Mg.
出处 《山东大学学报(医学版)》 CAS 北大核心 2007年第5期459-461,466,共4页 Journal of Shandong University:Health Sciences
基金 山东省自然科学基金资助课题(Y2006C35) 济南市青年科技明星计划(200205)
关键词 螯合剂 肌酐 尿素氮 尿酸 必需元素 Aluminum Chelating agents Cr BUN UA Essential elements
  • 相关文献

参考文献8

  • 1Nayak P.Aluminum:impacts and disease[J].Environmental Research,2002,89(A):101-115.
  • 2Kattamis A,Ladis V,Berdousi H,et al.Iron chelation treatment with combined therapy with deferiprone and deferioxamine:A 12-month trial[J].Blood Cells,Molecules,and Diseases,2006,36(1):21-25.
  • 3Sharmaa P,Shahb ZA,Kumara A,et al.Role of combined administration of Tiron and glutathione against aluminum-induced oxidative stress in rat brain[J].Journal of Trace Elements in Medicine and Biology,2007,21(1):63-70.
  • 4Yokel RA.Aluminum chelation principles and recent advances[J].Coordination Chemistry Reviews,2002,228(1):97-113.
  • 5Chakraborty D,Bhattacharyya M.Deferiprone(L1) induced conformation change of hemoglobin:A fluorescence and CD spectroscopic study[J].Molecular and Cellular Biochemistry,2000,204(1):17-20.
  • 6Ping L,Xi C,Shide W,et al.The combined effects of the chelating agent deferiprone,ascorbic acic and mesna on urinary aluminum excretion in rabbits[J].Trace Element and Electrolytes,2003,20(2):79-82.
  • 7刘萍,崔惠平,吴世德,董怀军,姚玉娜,冯国昌.铝螯合剂对尿中微量元素排出的影响[J].中国公共卫生,2005,21(12):1443-1444. 被引量:2
  • 8Liu P,Wu SD,Yao YN,et al.Protective effect of deferiprone on damaged genetic material of mice induced by alum[J].Trace Elements and Electrolytes,2005,22(2):127-132.

二级参考文献9

  • 1Yokel RA.The toxicology of aluminum in the brain:a review[J].Neurotoxicology,2000,21(6):813-828.
  • 2Bosque MA,Domingo J L,Corbella J.Assessment of the developmental toxicity of deferosamine in mice[J].Arch Toxicol,1995,67(7):467.
  • 3Kontoghiorghes GJ.Comparatice efficacy and toxicity of desferrioxamine,deferiprone and other iron and aluminum chelation drugs[J].Toxicol Lett,1995,80(1):1-18.
  • 4Gavino Faa,Guido Crisponi.Iron chelating agents in clinical practice[J].Coordination Chemistry Reviews,1999,184(1):291-310.
  • 5Kontoghiorghes GJ.Dose response studies using desferrioxamine and orally active chelators in a mouse model[J].Scand J Haematol,1986,37(1):63-67.
  • 6Kontoghiorghes GJ,Aldouri MA,Hoffiband AV,et al.Effective chelation of iron in thalassaemia with the oral chelator 1,2-dimethy1-3-hydroxypyrid-4-one[J].British Medical Journal,1987,295(12):1509-1512.
  • 7Jason D Czachor,M George Cherian,James Koropatnick.Reduction of copper and metallothionein in toxic mik mice by tetratiomolybdate,but not deferiprone[J].Journal of Inorganic Biochemistry,2002,88(2):213-222.
  • 8MJ Kersten,R Lange,MEP Smeets,et al.Long-term treatment of transfusional iron overload with the oral iron chelator,1,2-dimethy1-3-hydroxypyrid-4one (deferiprone)[J].Abstracts/Netherlands Journal of Medicine,1995,47(5):A55.
  • 9刘萍,吴世德,王淑娥,张廷国,崔晞,张彦林.经口摄入硫酸铝钾对兔肝肾影响的实验研究[J].中国公共卫生,2002,18(8):905-906. 被引量:10

共引文献1

同被引文献42

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部